Cargando…

Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing

A new solution for local anesthetic and antibiotic delivery after eye surgery is presented. A contact lens-shaped collagen drug carrier was created and loaded by Levofloxacin and Tetracaine with a riboflavin crosslinked surface layer, thus impeding diffusion. The crosslinking was confirmed by Raman...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbánek, Pavel, Šuly, Pavol, Ševčík, Jakub, Hanulíková, Barbora, Kuřitka, Ivo, Šopík, Tomáš, Stodůlka, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143253/
https://www.ncbi.nlm.nih.gov/pubmed/37111260
http://dx.doi.org/10.3390/ph16040505
_version_ 1785033807809740800
author Urbánek, Pavel
Šuly, Pavol
Ševčík, Jakub
Hanulíková, Barbora
Kuřitka, Ivo
Šopík, Tomáš
Stodůlka, Pavel
author_facet Urbánek, Pavel
Šuly, Pavol
Ševčík, Jakub
Hanulíková, Barbora
Kuřitka, Ivo
Šopík, Tomáš
Stodůlka, Pavel
author_sort Urbánek, Pavel
collection PubMed
description A new solution for local anesthetic and antibiotic delivery after eye surgery is presented. A contact lens-shaped collagen drug carrier was created and loaded by Levofloxacin and Tetracaine with a riboflavin crosslinked surface layer, thus impeding diffusion. The crosslinking was confirmed by Raman spectroscopy, whereas the drug release was investigated using UV-Vis spectrometry. Due to the surface barrier, the drug gradually releases into the corneal tissue. To test the function of the carrier, a 3D printed device and a new test method for a controlled drug release, which mimics the geometry and physiological lacrimation rate of the human eye, were developed. The experimental setup with simple geometry revealed that the prepared drug delivery device can provide the prolonged release profile of the pseudo-first-order for up to 72 h. The efficiency of the drug delivery was further demonstrated using a dead porcine cornea as a drug recipient, without the need to use live animals for testing. Our drug delivery system significantly surpasses the efficiency of antibiotic and anesthetic eyedrops that would have to be applied approximately 30 times per hour to achieve the same dose as that delivered continuously by our device.
format Online
Article
Text
id pubmed-10143253
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101432532023-04-29 Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing Urbánek, Pavel Šuly, Pavol Ševčík, Jakub Hanulíková, Barbora Kuřitka, Ivo Šopík, Tomáš Stodůlka, Pavel Pharmaceuticals (Basel) Article A new solution for local anesthetic and antibiotic delivery after eye surgery is presented. A contact lens-shaped collagen drug carrier was created and loaded by Levofloxacin and Tetracaine with a riboflavin crosslinked surface layer, thus impeding diffusion. The crosslinking was confirmed by Raman spectroscopy, whereas the drug release was investigated using UV-Vis spectrometry. Due to the surface barrier, the drug gradually releases into the corneal tissue. To test the function of the carrier, a 3D printed device and a new test method for a controlled drug release, which mimics the geometry and physiological lacrimation rate of the human eye, were developed. The experimental setup with simple geometry revealed that the prepared drug delivery device can provide the prolonged release profile of the pseudo-first-order for up to 72 h. The efficiency of the drug delivery was further demonstrated using a dead porcine cornea as a drug recipient, without the need to use live animals for testing. Our drug delivery system significantly surpasses the efficiency of antibiotic and anesthetic eyedrops that would have to be applied approximately 30 times per hour to achieve the same dose as that delivered continuously by our device. MDPI 2023-03-28 /pmc/articles/PMC10143253/ /pubmed/37111260 http://dx.doi.org/10.3390/ph16040505 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Urbánek, Pavel
Šuly, Pavol
Ševčík, Jakub
Hanulíková, Barbora
Kuřitka, Ivo
Šopík, Tomáš
Stodůlka, Pavel
Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title_full Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title_fullStr Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title_full_unstemmed Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title_short Controlled Drug Delivery Device for Cornea Treatment and Novel Method for Its Testing
title_sort controlled drug delivery device for cornea treatment and novel method for its testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143253/
https://www.ncbi.nlm.nih.gov/pubmed/37111260
http://dx.doi.org/10.3390/ph16040505
work_keys_str_mv AT urbanekpavel controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT sulypavol controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT sevcikjakub controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT hanulikovabarbora controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT kuritkaivo controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT sopiktomas controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting
AT stodulkapavel controlleddrugdeliverydeviceforcorneatreatmentandnovelmethodforitstesting